New findings by a team of molecular biologists at Brown University on the critical role of a protein called AIMP3 in heart ...

While heart disease has been the leading cause of death in the U.S. for over a century, the past 50 years have seen a ...

Ancora Heart announced it has reached the first enrollment milestone in its CORCINCH-HF pivotal trial evaluating the ...

Defect-free quadruple medication therapy significantly improved at discharge, 30 days in patients with heart failure with reduced ejection fraction.

Brown University biologists found that when a protein called AIMP3 was removed from heart cells in mice, it led to severe ...

Researchers from Philadelphia-based Temple University Health System have developed an EHR-integrated tool to detect pulmonary arterial hypertension, a form of heart failure, according to a study ...

Learn how finerenone improves heart failure outcomes in frail patients - discover the latest evidence and clinical guidance.

The syndrome of heart failure is characterized by adverse structural changes (cardiac remodeling) and an inexorable progression of disease that continues to occur even after the initial injury has ...

The challenge for Bayer will be carving out a role for Kerendia in mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF) heart failure alongside SGLT2 inhibitors – AstraZeneca's Farxiga ...

Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

The FDA has followed the advice of its expert advisors and rejected Cytokinetics’ cardiac myosin activator omecamtiv mecarbil as a treatment for heart failure, saying the efficacy data for the ...

Rare heart gene brings on sudden cardiac arrest for Bay area father and son BY Erin Murray Tampa UPDATED 3:12 PM ET Mar. 09, 2025 PUBLISHED 10:10 AM ET Mar. 09, 2025 PUBLISHED 10:10 AM EDT Mar. 09 ...